FI63744C - Foerfarande foer framstaellning av nya spasmolytiska tyrosinderivat - Google Patents
Foerfarande foer framstaellning av nya spasmolytiska tyrosinderivat Download PDFInfo
- Publication number
- FI63744C FI63744C FI750256A FI750256A FI63744C FI 63744 C FI63744 C FI 63744C FI 750256 A FI750256 A FI 750256A FI 750256 A FI750256 A FI 750256A FI 63744 C FI63744 C FI 63744C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- cbz
- group
- give
- alk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (3)
1. Förfarande för framställning av nya terapeutiskt använd-bara D,L-N-acyltyrosinamider med formeln Λ \ R3 J^N-Alk-O -// ch9-ch-co-n<; VI «6^ \=/ »H \r4 CO K väri Alk är en rak eller förgrenad alkylgrupp med 1-6 kolatomer, och Rg är lika eller olika, raka eller förgrenade alkylgrupper med 1-4 kolatomer eller bildar tillsammans en alkylengrupp med 4-5 kolatomer, som med N-atomen bildar en heterocyklisk ring innehällande eventuellt en ytterligare N-atom (N')» vilken kan vara substituerad med en metyl-, hydroxietyl- eller bensylgrupp, vilken heterocyklisk grupp företrädesvis är en pyrrolidino-, piperidino- eller N'-substituerad piperazinogrupp, R2 är en fenylgrupp, som kan vara substituerad i orto-, meta- eller para-ställningarna med en eller tvä substituenter av följande: klor, brom, nitro, metoxi, metyl eller trifluormetyl, R^ och R^ är lika eller olika och betecknar väte, en rak eller förgrenad alkyl- eller aralkylgrupp, varvid deras sammanräknande antal av kolatomer är högst 8, och farmaceutiskt god-tagbara salter av dessa föreningar, kännetecknat därav, att man a) omsätter L- eller D,L-tyrosin i en Schotten-Baumann-reaktion i molförhallandet 1:2 med bensyloxikarbonylklorid, varvid men erhäller 0,N-(dibensyloxikarbonyl)tyrosin med formeln Cbz-0 / V ch9-ch-cooh I \=/ NH Cbz väri Cbz är en bensyloxikarbonylgrupp, n 63744 27 b) omsätter 0,N-(dibensyloxikarbonyl)tyrosinen med formeln I i ett inert organiskt lösningsmedel vid -15 - +5°C med en tertiär organisk amin, företrädesvis med trietylamin, och etyl-, propyl-eller butylestern av klormyrsyran till en blandanhydrid, vilken man omsätter vid -10 - +20°C med en amin med formln R3 J^-NH VIII R4 vari och har ovan nämnda betydelse, varvid man erhäller tyrosinamid med formeln // \ ^R3 Cbz-0 —// XV CH2-CH-CO-N^" II W NH ^ R4 I ’ Cbz väri R^/ R4 och Cbz har ovan nämnda betydelse, c) avspjälkar O-bensyloxikarbonylgruppen av föreningen med formeln II genom hydrolysering med en organisk bas i vatten- eller vatten-alkohollösning vid 20-60°C, varvid man erhäller N-bensyl-oxikarbonyltyrosinamid med formeln // \ R3 ho -4/ xVch2-ch-co-nCT m \-/ NH ^R4 Cbz väri Cbz, R^ och R4 har ovan nämnda betydelse, d) hydrerar katalytiskt N-bensyloxikarbonyltyrosinamiden med formeln III, varvid man erhäller tyrosinamid med formeln // \ HO-// 'V- CH2-CH-CO-N^ IV \=J nh2 ^r4 28 63744 väri och R4 har ovan nämnda betydelse, e) omsätter tyrosinamiden med formeln IV i ett organiskt lösningsmedel vid 0-10°C i närvaro av en oorganisk bas med en syra-klorid med formeln R2C0C1 IX väri R2 har ovan nämnda betydelse, varvid man erhäller N-acyltyrosin-amid med formeln HO _// XV CH2-CH-CO-NCy V \— / nh ^r4 CO K2 väri R2, R^ och R4 har ovan nämnda betydelse, f) omvandlar tyrosinamiden med formlen V tili natriumsaltet, som man omsätter i ett vattenfritt organiskt lösningsmedel vid för-höjd temperatur, högst 120°C, med en halogenalkylamin med formeln 'yrN-Alk-X VII H väri R^, Rg och Alk har ovan nämnda betydelse, och X är halogen, och g) om man sä önskar, omvandlar den erhällna basen med formeln VI tili ett farmaceutiskt godtagbart sait.
2. Förfarande enligt patentkravet 1, kännetecknat därav, att man som halogenalkylamin med formeln VII använder en halogenalkylamin med formeln V N-Alk'-X Vila V
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT6728674 | 1974-02-01 | ||
IT67286/74A IT1062206B (it) | 1974-02-01 | 1974-02-01 | Derivati della tirosina attivi sulla muscolatura liscia |
Publications (3)
Publication Number | Publication Date |
---|---|
FI750256A FI750256A (sv) | 1975-08-02 |
FI63744B FI63744B (fi) | 1983-04-29 |
FI63744C true FI63744C (fi) | 1983-08-10 |
Family
ID=11301149
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI750256A FI63744C (fi) | 1974-02-01 | 1975-01-30 | Foerfarande foer framstaellning av nya spasmolytiska tyrosinderivat |
FI750255A FI61479C (fi) | 1974-02-01 | 1975-01-30 | Foerfarande foer framstaellning av spasmolytiska nya d,l-tyrosinderivat |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI750255A FI61479C (fi) | 1974-02-01 | 1975-01-30 | Foerfarande foer framstaellning av spasmolytiska nya d,l-tyrosinderivat |
Country Status (19)
Country | Link |
---|---|
US (1) | US4004008A (sv) |
JP (2) | JPS5417728B2 (sv) |
AT (2) | AT343632B (sv) |
BE (1) | BE824995A (sv) |
CA (2) | CA1047498A (sv) |
CH (2) | CH605658A5 (sv) |
DE (1) | DE2503992C2 (sv) |
ES (1) | ES434323A1 (sv) |
FI (2) | FI63744C (sv) |
FR (1) | FR2259592B1 (sv) |
GB (1) | GB1467927A (sv) |
HK (1) | HK38979A (sv) |
HU (2) | HU175156B (sv) |
IN (1) | IN139364B (sv) |
IT (1) | IT1062206B (sv) |
NL (1) | NL167683C (sv) |
NO (2) | NO144211C (sv) |
SE (2) | SE413094B (sv) |
ZA (1) | ZA75530B (sv) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5225243A (en) * | 1975-08-20 | 1977-02-25 | Toshiba Electric Equip Corp | Distributing panel |
US4579866A (en) * | 1984-05-29 | 1986-04-01 | Usv Pharmaceutical Corp. | Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents |
US5198458A (en) * | 1986-02-04 | 1993-03-30 | Suntory Limited | Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same |
CA1320734C (en) * | 1986-02-04 | 1993-07-27 | Suntory Limited | Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same |
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
US5258407A (en) * | 1991-12-31 | 1993-11-02 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
US5206373A (en) * | 1992-02-28 | 1993-04-27 | Merck & Co., Inc. | Process for preparing fibrinogen receptor antagonists |
DE10204951A1 (de) * | 2002-02-06 | 2003-08-14 | Basf Ag | Phenylalaninderivate als Herbizide |
CN1894202A (zh) * | 2003-12-19 | 2007-01-10 | 巴斯福股份公司 | 苯甲酰基取代的苯基丙氨酸酰胺 |
AU2006270914B2 (en) * | 2005-07-19 | 2011-01-20 | Daiichi Sankyo Company, Limited | Substituted propanamide derivative and pharmaceutical composition containing the same |
WO2011094890A1 (en) * | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
EP2579888A2 (en) | 2010-06-09 | 2013-04-17 | Receptos, Inc. | Novel glp-1 receptor stabilizers and modulators |
WO2012166951A1 (en) | 2011-05-31 | 2012-12-06 | Receptos, Inc. | Novel glp-1 receptor stabilizers and modulators |
RU2634896C2 (ru) | 2011-12-12 | 2017-11-08 | Селджин Интернэшнл Ii Сарл | Новые модуляторы рецептора glp-1 |
CN102659619A (zh) * | 2012-04-18 | 2012-09-12 | 上海骏捷生化科技有限公司 | 一种合成酪氨酸衍生物的方法 |
CN103508921B (zh) * | 2012-06-21 | 2015-09-30 | 贵州百灵企业集团制药股份有限公司 | 一种苯丙氨醇化合物的制备方法 |
CN103508920B (zh) * | 2012-06-21 | 2016-03-02 | 贵州百灵企业集团制药股份有限公司 | 一种苯丙氨醇化合物的光学异构体的制备方法及其用途 |
EP3008056B8 (en) | 2013-06-11 | 2021-03-03 | Receptos Llc | Novel glp-1 receptor modulators |
MX2017000972A (es) | 2014-07-25 | 2017-07-27 | Celgene Int Ii Sarl | Nuevos moduladores del receptor de peptido similar a glucagon 1 (glp-1). |
JP2017538711A (ja) | 2014-12-10 | 2017-12-28 | セルジーン インターナショナル ツー エスエーアールエル | Glp−1レセプターモジュレーター |
CN107417560B (zh) * | 2017-03-30 | 2020-05-22 | 上海常丰生物医药科技有限公司 | 一种合成盐酸替罗酰胺的方法 |
CN110015978B (zh) * | 2019-04-29 | 2021-03-19 | 康化(上海)新药研发有限公司 | O-[2-[[叔丁氧羰基]氨基]乙基]-n-[芴甲氧羰基]-l-酪氨酸的合成方法 |
CN115850107A (zh) * | 2022-11-30 | 2023-03-28 | 苏州诚和医药化学有限公司 | 一种工业化合成盐酸替罗酰胺的方法 |
-
1974
- 1974-02-01 IT IT67286/74A patent/IT1062206B/it active Protection Beyond IP Right Term
-
1975
- 1975-01-22 GB GB287875A patent/GB1467927A/en not_active Expired
- 1975-01-24 ZA ZA00750530A patent/ZA75530B/xx unknown
- 1975-01-29 IN IN179/CAL/75A patent/IN139364B/en unknown
- 1975-01-30 CH CH110975A patent/CH605658A5/xx not_active IP Right Cessation
- 1975-01-30 NO NO750288A patent/NO144211C/no unknown
- 1975-01-30 FI FI750256A patent/FI63744C/fi not_active IP Right Cessation
- 1975-01-30 FI FI750255A patent/FI61479C/fi not_active IP Right Cessation
- 1975-01-30 CA CA219,027A patent/CA1047498A/en not_active Expired
- 1975-01-30 CA CA75219028A patent/CA1048503A/en not_active Expired
- 1975-01-30 NO NO750287A patent/NO144210C/no unknown
- 1975-01-30 BE BE152889A patent/BE824995A/xx not_active IP Right Cessation
- 1975-01-30 CH CH110875A patent/CH605657A5/xx not_active IP Right Cessation
- 1975-01-31 AT AT74675A patent/AT343632B/de not_active IP Right Cessation
- 1975-01-31 ES ES434323A patent/ES434323A1/es not_active Expired
- 1975-01-31 SE SE7501115A patent/SE413094B/sv unknown
- 1975-01-31 FR FR7503079A patent/FR2259592B1/fr not_active Expired
- 1975-01-31 AT AT74575A patent/AT342026B/de not_active IP Right Cessation
- 1975-01-31 JP JP1326675A patent/JPS5417728B2/ja not_active Expired
- 1975-01-31 NL NL7501193A patent/NL167683C/xx not_active IP Right Cessation
- 1975-01-31 JP JP1328575A patent/JPS5417729B2/ja not_active Expired
- 1975-01-31 HU HU75RO821A patent/HU175156B/hu unknown
- 1975-01-31 DE DE2503992A patent/DE2503992C2/de not_active Expired
- 1975-01-31 SE SE7501114A patent/SE410850B/sv not_active IP Right Cessation
- 1975-01-31 HU HU75RO820A patent/HU174825B/hu unknown
- 1975-02-03 US US05/546,481 patent/US4004008A/en not_active Expired - Lifetime
-
1979
- 1979-06-14 HK HK389/79A patent/HK38979A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI63744C (fi) | Foerfarande foer framstaellning av nya spasmolytiska tyrosinderivat | |
PL100614B1 (pl) | Sposob wytwarzania nowych,eterowych pochodnych oksymu | |
JPH0210821B2 (sv) | ||
US5712269A (en) | M2 receptor ligand for the treatment of neurological disorders | |
KR900006118B1 (ko) | 4-퀴놀론 유도체의 제법 | |
LU82236A1 (fr) | 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique | |
JPH09512815A (ja) | 新規ヒドロキシム酸誘導体、それらを含む医薬組成物およびその製造法 | |
TW200304823A (en) | Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as medicament, and medicament containing them | |
AU607659B2 (en) | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents | |
FI60863B (fi) | Foerfarande foer framstaellning av nya bentshydryloxialkylaminderivat med foerlaengd antihistamineffekt | |
CN113214238A (zh) | 一类具有酰化哌嗪结构的吲哚恶二唑衍生物的制备和用途 | |
PT839137E (pt) | Diamidas acidas aromaticas com accao antigastrina um metodo para a sua preparacao e para o seu uso farmaceutico | |
Elliott et al. | Central nervous system activity of 7-substituted 1-azaphenoxathiin analogs and their oxidation products | |
US3946018A (en) | 1,4-Dihydro-3 (2H)-isoquinolinone derivatives | |
PT94750A (pt) | Processo para a preparacao de benzoxazolonas 4,5,6,7-tetra-substituidas | |
NL8205038A (nl) | Esters van 4-hydroxymethyl-1-ftalazonderivaten en zouten daarvan. | |
JPS61100555A (ja) | ベンゾフエノンオキシム誘導体 | |
JPS5827790B2 (ja) | 置換1,2,4,5−テトラヒドロ−3h,3−ベンゾアゼピン類 | |
DE2030714A1 (de) | Neue tricychsche Verbindungen und Verfahren zu ihrer Herstellung | |
JPH05506654A (ja) | 1,5―ベンゾチアゼピノン誘導体、その製法および医薬品用途 | |
CA2561601C (en) | Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease | |
JP3359722B2 (ja) | メトトレキセート誘導体 | |
JPS591279B2 (ja) | 新規ヘレブリゲニンアシル誘導体、その製法及び該誘導体を含有する陽性走心筋作用医薬 | |
US3544689A (en) | Methods and compositions for treating spasms employing 3',4' - dimethoxy - 6 - (2-(p - methoxyphenyl) - 1 - alkyl - alkyl-ethylamino) - hexanophenones and the salts thereof | |
DE2843328A1 (de) | Phenylacetamidverbindungen und sie enthaltende zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: ROTTA RESEARCH LABORATORIUM S.P.A. |